Drugs / Alum-ALM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00429715 | Jan → May 2007 | — | Tehran University of Medical Sciences | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00429780 Comparator | Jan → Sep 2007 | — | Tehran University of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alum-ALM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00429780 ↗ |
| Modality | Vaccine | “An autoclaved L. major vaccine (ALM) mixed with BCG has been tested” NCT00429780 ↗ |
| Route | Other | “will be injected twice (30 days apart)” NCT00429780 ↗ |